VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, January 5, 2026
Stock Comparison
Emerson Electric Co. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Emerson Electric Co.
EMR · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Emerson Electric Co.'s moat claims, evidence, and risks.
View EMR analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 70 / 100 for Emerson Electric Co.).
- Segment focus: Emerson Electric Co. has 6 segments (24.2% in Final Control); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Emerson Electric Co. has 10 moat types across 4 domains; Sanofi has 5 across 3.
Primary market context
Emerson Electric Co.
Final Control
Industrial control valves, isolation/shutoff valves, pressure relief & safety valves, actuators and regulators
Global
Process & hybrid manufacturers
Automation components supplier
24.2%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Emerson Electric Co. strengths
Sanofi strengths
Segment mix
Emerson Electric Co. segments
Full profile >Final Control
Oligopoly
Measurement & Analytical
Oligopoly
Discrete Automation
Competitive
Safety & Productivity
Competitive
Control Systems & Software
Oligopoly
Test & Measurement
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.